Good morning, everyone, and welcome to the start of the next election season. Well, maybe this can wait a few days. But now that the latest election is over, the time has come to re-focus on matters at hand. To get started, yes, we are brewing that delicious cup of stimulation - Southern Pecan, in fact - and invite you to join us. As always, there is much to do. We know you have the same challenge, so here are some items of interest to help you along. Have a great day and do stay in touch...
Congress Subpoenas Co-Owner Of Compounding Pharmacy (Reuters)
Roche Gets Priority Review For Herceptin Successor (Pharma Times)
Express Scripts Gets Subpoena From Justice Department (Commercial Appeal)
Glaxo Pulls Vaccine Batch In Canade Over Contamination (InPharma Technologist)
Canadian Supreme Court To Rule On Viagra Patent (Montreal Gazette)
Novo Insulin Has Safety Risks: FDA Staff (Bloomberg News)
KV Pharma Settles Suit With Illinois Over Makena (Crain's Chicago Business)
Vivus Diet Pill Sales Are Slower Than Expected (Bloomberg News)
GE Invests In Another CRO (Outsourcing Pharma)
USP Revises Heparin Labeling Guide (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates
steaming coffee pix thx to dleggett on flickr
2 Comments
As a follow-on to your wisdom above, here's a "guest commentator" -
http://www.gocomics.com/nonsequitur/2012/11/07
Your "guest commentator" was great and I am also thankful that we in the swing/battleground states will be returning to our normal level of robo-calls!